​1. Prof. Violet Kasabri registered two patencies: 

1. Use Of Substituted Quinolone Derivatives For Treating Cancer 8/3/2022, Under Number WO PCT/JO2022/050004​
   
2. Novel Substituted Quinolones, Methods Of Preparation Thereof, And Their Use For Treating Microbial Infections: 24/2/2022, Under Number WO2022038645 with PCT/JO2020/050006
   

2. Prof. Violet Kasabri AWARDED certification of RECOGNITION of valuable invention in ceremony by ‘’Innovation and Entrepreneurship Center/University of Jordan; 22/1/2023.​
3. Prof. V. Kasabri, Prof. Almotassem Yousef  and coauthors' poster awarded FIRST POSTER AWARD in Poster Competition at the Annual Conference for Graduate Studies/THE UNIVERSITY OF JORDAN 23^rd-24th/4/2025 (FIRST POSTER AWARD in Poster Competition): ‘’Genetic Polymorphisms in DRVT Gene (rs6432860) and Pharmacoresistance to Antiepileptic Drugs among Jordanian Patients with Epilepsy’

4. Dr. Mohammed ​​​Zawiah nominated as an Academic Editor for PLOS One Journal and Frontiers in Public Health Journal.

5. Dr. Mohammed ​​​Zawiah​ ​is a collaborator in the Global Burden of Disease (GBD) group.​

6. PharmD Batool Al-khawaldeh awarded the global credential by Sales and Marketing Certification Institute​. December 12, 2024. 

7. Manuscript co-authored by Prof. N. Bulatova, Prof. V. Kasabri and Dr. Maysa Suyagh accepted in Scopus Q1 journal "Pharmacy Practice": 

Sameeha Alshelleh, Maysa Suyagh, Hussein Alhawari, Nailya Bulatova, VIOLET KASABRI, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa; ‘’ Combinatorial Multiplicity of Cardiometabolic and Inflammatory Markers in Gum Arabica Modality of CKD CAM: Part 2.

​